Laboratory Corp of America
Laboratory Corporation of America Holdings (NYSE: LH), more commonly known as LabCorp, is an S&P; 500 company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories. Before a merger with National Health Laboratory in 1995, the company operated under the name Roche BioMedical. LabCorp performs its largest volume of specialty testing at its Center for Esoteric Testing in Burlington, North Carolina, where the company is headquartered.
Campaign Finance$333,651 Given
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
- Employee Color Block
- PAC Color Block
Republicans vs. Democratsin dollars. "Other" includes 3rd parties and organizations without official party affiliation.
State vs. Federalin dollars
Top PAC Recipients
- Employee Color Block
- PAC Color Block
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Laboratory Corp of America
Names of Lobbyists
Firm Hired Amount Laboratory Corp of America $400,000
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Medicare & Medicaid,
- Medical Research & Clin Labs,
Most Frequently Disclosed Bills
Bill No. Title H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Service Members Home Ownership Tax Act of 2009 H.R.4872 Health Care and Education Affordability Reconciliation Act of 2010 H.R.3207 Modernizing Laboratory Test Standards for Patients Act of 2011 H.R.3200 Local Flexibility for Transit Assistance Act H.R.3962 Affordable Health Care for America Act H.R.4994 Medicare and Medicaid Extenders Act of 2010 H.R.3630 Middle Class Tax Relief and Job Creation Act of 2011
RegulationsMentioned in 106 dockets; Submitted to 10 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Laboratory Corp of America" in public comments on proposed federal regulations.
Documents Submitted by the Organization
View all submissions data for Laboratory Corp of America
- Toggle 2 DOT Procedures for Transportation Workplace Drug and Alcohol Testing Programs 2003
- Toggle 1 OSHA Infectious Diseases 2010
- Toggle 1 PHMSA Combination Packages Containing Liquids intended for Transport by Air Craft 2007
- Toggle 1 HHS Meaningful use of Healthcare Information Technology 2009
- Toggle 1 SAMHSA Request For Information- Mandatory Guidelines for Federal Workplace Drug Testing Programs; Request for Information Regarding Specific Issues Related to the Use of the Oral Fluid Specimen for Drug Testing 2011
- Toggle 1 PHMSA Hazardous Materials: Revision of Requirements for Security Plans 2006
- Toggle 1 CDC Foreign Quarantine; Etiological Agents, Hosts, and Vectors 2011
- Toggle 1 FAA In the Matter of Laboratory Corporation of America Holdings - CP08EA0011 2008
- Toggle 1 DOT Procedures for Transportation Workplace Drug and Alcohol Testing Program 2010
- Toggle 1 PHMSA Harmonization With the United Nations Recommendations, International Maritime Dangerous Goods Code, and International Civil Aviation Organization's Technical Instructions - Notice and Request for Comments 2006
Mentions in Document Text
View all mentions data for Laboratory Corp of America
- Toggle 36 CY 2014 Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Medicare Part B CMS-1600-P 2013
- Toggle 13 NIH Recently Posted NIH Rules and Notices. Unknown
- Toggle 8 FAA In the Matter of Laboratory Corporation of America - CP09NM0001 2009
- Toggle 7 FAA In the Matter of Laboratory Corporation of America Holdings - CP08EA0011 2008
- Toggle 3 DOT Electronic Transmission and Storage of Drug Testing Information Federal Advisory Committee; Meeting 2002
- Toggle 3 PHMSA Harmonization With the United Nations Recommendations, International Maritime Dangerous Goods Code, and International Civil Aviation Organization's Technical Instructions - Notice and Request for Comments 2006
- Toggle 3 EPA Hazardous Waste Management System; Revisions to the Definition of Solid Waste - Phase I 2002
- Toggle 2 PHMSA Combination Packages Containing Liquids intended for Transport by Air Craft 2007
- Toggle 2 FDA To Determine Whether Vesanoid (Tretinoin) Capsules, 10 mg, Approved Under NDA 20-438, has Been Voluntarily Withdrawn for Safety or Efficacy Reasons 2010
- Toggle 2 OSHA RECORDING AND REPORTING OCCUPATIONAL ILLNESSES AND INJURIES 2006